References
sarcopenia
REGRESSION, SARCOPENIA
Schematic overview of the study and treatment arms.Study design.Clinical associations between sarcopenia with age, serum C-RP levels, serum NT-proBNP, and LVEF determined by transthoracic ultrasound. Legend: C-RP: c-reactive protein; ns: non-significative; *: Significant clinical correlations between serum NT-proBNP levels and LVEF and nutritional parameters at baseline (Change in LVEF and serum NT-pro BNP serum levels after 24 weeks of nutritional intervention with Mediterranean diet (control group) and Mediterranean diet plus two hypercaloric, hyperproteic oral supplements (Oss). Legend: *: Baseline clinical characteristics of the patients. Comparison between groups based on the nutritional intervention.Legend: Categorical data are presented as percentages and the absolute number in brackets.Clinical characteristics of the patients twenty-four weeks after nutritional support.Legend: Categorical data are presented in percentages and the absolute number in brackets.Morphofunctional assessment of the nutritional status at baseline and six months after nutritional treatment.Legend: RF: rectus femoris. p1 refers to the comparison between all patients at baseline and after twenty-four weeks; p2 refers to the comparison between patients of the control group (Mediterranean diet) at baseline and after twenty-four weeks; p3 refers to the comparison between patients of the intervention group (Mediterranean diet plus oral nutritional supplementation) at baseline and after twenty-four weeks.Biochemical analysis at baseline and six months after nutritional support.p1 refers to the comparison between all patients at baseline and after twenty-four weeks; p2 refers to the comparison between patients of the control group (Mediterranean diet) at baseline and after twenty-four weeks; p3 refers to the comparison between patients of the intervention group (Mediterranean diet plus oral nutritional supplementation) at baseline and after twenty-four weeks.Multivariate logistic regression for mortality and new hospital admissions in patients with HF that received nutritional support after adjusting by age and sex.